drug
TSRA-196
Phase 2updated 3mo agoby Tessera Therapeutics Inc
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying TSRA-196
News(2)
- Aura, Schrödinger trim workforcesFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 1d ago
- Chutes & Ladders—Legend CEO departs without successor in placeLegend Biotech CEO Ying Huang, Ph.D., has left the company suddenly, without a predecessor in place. Huang was elevated from CFO to CEO in 2020 after a Chinese customs investigation was opened on f…fiercebiotech · 12d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that